Uridine triacetate is a medication that is used to treat patients who have a deficiency in the enzyme dihydropyrimidine dehydrogenase (DPD). This enzyme is responsible for breaking down certain medications, including fluorouracil, which is commonly used in cancer treatment. Patients who have a DPD deficiency may experience severe and potentially life-threatening side effects when taking medications that are metabolized by this enzyme.
Uridine triacetate works by providing an alternative pathway for the breakdown of these medications, reducing the risk of toxicity in patients with a DPD deficiency. It is typically administered orally and is well-tolerated by most patients.
It is important to follow your healthcare provider’s instructions when taking uridine triacetate, as the dosage and frequency of administration will vary depending on your individual circumstances. Your healthcare provider will also monitor you closely for any signs of side effects or complications while taking this medication.
While uridine triacetate can be a life-saving treatment for patients with a DPD deficiency, it is important to be aware of potential drug interactions and side effects. Be sure to inform your healthcare provider of any other medications or supplements you are taking before starting uridine triacetate.
If you have been prescribed uridine triacetate, it is important to take it as directed and to keep all follow-up appointments with your healthcare provider. By working closely with your healthcare team, you can ensure that you are receiving the best possible care and treatment for your condition.
EN 
ES 
FR 
PT 
ZH